Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
National Cancer Institute (NCI)
Mayo Clinic
Thomas Jefferson University
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Ankyra Therapeutics, Inc
Regeneron Pharmaceuticals
OncoNano Medicine, Inc.
Regeneron Pharmaceuticals
H. Lee Moffitt Cancer Center and Research Institute
University of Pittsburgh
Instituto de Investigación Biomédica de Salamanca
Vyriad, Inc.
OncoResponse, Inc.